Cofactor Genomics
YC S15St. Louis, US · Founded 2015 · 13 employees · 3 known investors
Cofactor Genomics develops predictive diagnostics for cancer immunotherapy using RNA-expression models to characterize tumor microenvironments and predict patient response. The company serves oncology and precision medicine markets by enabling more accurate patient-to-therapy matching.
AI & Machine LearningBiotechHealthtechMedical DevicesDiagnosticsin /cofactorgenomics/@cofactorgenomic
Founders & leadership· Y Combinator alumni (S15)
Dave Messinain𝕏Founder/COO
Jarret GlasscockinFounder & CEO
Investors · 3
In the news
- In Brief This Week: Cofactor Genomics, Biocartis, Caris Life Sciences, More | GenomeWebgenomeweb.com · 2025
- Cofactor Genomics Receives Investment from Labcorp and Ascension Venturesfinsmes.com · 2025
- Cofactor Genomics - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Investors – Cofactor Genomicscofactorgenomics.com · 2019
- Cofactor Genomics Announces $18 Million Funding In An Oversubscribed Series-A Round To Bring RNA To Precision Medicine - BioSpacebiospace.com · 2017
- Cofactor Genomics Awarded $1.5M NIH Grant for Circular RNA Enrichment Tech | GenomeWebgenomeweb.com · 2015